๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
1890188 60 F VA 11/22/2021 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
MODERNA
MODERNA
MODERNA
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 FJ1620
030L20A
030L20A
030L20A
FJ1620
FJ1620
FJ1620
Extra dose administered; Arthralgia, Back pain, Blood test, Electromyogram, Fall... Extra dose administered; Arthralgia, Back pain, Blood test, Electromyogram, Fall; Gait disturbance, Incorrect dose administered, Inflammation, Magnetic resonance imaging, Muscular weakness; Pain, Post vaccination syndrome; Arthralgia, Back pain, Blood test, Electromyogram, Fall; Gait disturbance, Incorrect dose administered, Inflammation, Magnetic resonance imaging, Muscular weakness; Pain, Post vaccination syndrome More
Error: Wrong Dose of Vaccine - Too High- Error: Wrong Dose of Vaccine - Too High-
2839357 33 F MO 05/04/2025 COVID19
MMR
 PFIZER\BIONTECH
MERCK & CO. INC.
 md3414
2053173
Pain; Pain Pain; Pain
Extreme soreness lasting >7 days Extreme soreness lasting >7 days
2839358 43 F UT 05/04/2025 PNC20
 PFIZER\WYETH
Fatigue, Headache, Malaise, Pain in extremity, Pallor Fatigue, Headache, Malaise, Pain in extremity, Pallor
Pallor, fatigue, malaise, headache, sore arm Pallor, fatigue, malaise, headache, sore arm
2839359 63 F FL 05/04/2025 PNC20
 PFIZER\WYETH
 LX4482
Extra dose administered Extra dose administered
The patient received Prevnar 20 on 5/2/2024, and received the same vaccine Prevnar 20 on 5/3/2025 The patient received Prevnar 20 on 5/2/2024, and received the same vaccine Prevnar 20 on 5/3/2025
2839360 65 F NJ 05/04/2025 PNC20
 PFIZER\WYETH
 LJ5284
Hyperhidrosis, Injection site pain, Loss of consciousness, Syncope Hyperhidrosis, Injection site pain, Loss of consciousness, Syncope
patient said vaccine was very painful and then fainted. Patient got sweaty, passed out on chair. I r... patient said vaccine was very painful and then fainted. Patient got sweaty, passed out on chair. I rubbed patients sternum and she woke up. patient refused help from 911. She accepted water and a cookie. Patient's son said she has fainted before during blood work. I checked her blood pressure and put on a fan to give her fresh air. She left after 45 minutes. More
2839361 62 F IN 05/04/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 47n3y
Extra dose administered, No adverse event Extra dose administered, No adverse event
no adverse reaction, she was given a 3rd dose of shingrix vaccine, she had the first 2 doses in 201... no adverse reaction, she was given a 3rd dose of shingrix vaccine, she had the first 2 doses in 2019 and 2020. patient had no adverse reaction More
2839362 79 F MN 05/04/2025 FLU3
 SANOFI PASTEUR
 u8515da
Injected limb mobility decreased, Pain in extremity Injected limb mobility decreased, Pain in extremity
Patient received the vaccine and a few days later she was having pain and difficulty raising her lef... Patient received the vaccine and a few days later she was having pain and difficulty raising her left arm More
2839363 38 M CO 05/04/2025 HEPAB
TYP
YF
 GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
SANOFI PASTEUR


Syncope, Tonic clonic movements; Syncope, Tonic clonic movements; Syncope, Tonic... Syncope, Tonic clonic movements; Syncope, Tonic clonic movements; Syncope, Tonic clonic movements More
The 3 above vaccines were administered. Patient experienced what appeared to be syncope with tonic-c... The 3 above vaccines were administered. Patient experienced what appeared to be syncope with tonic-clonic movement <1 hour after vaccine administration. Patient started to fall as exiting Immunization room and was supported to floor and monitored until EMS arrived and took over supporting patient. Patient did leave with EMS and it is thought that he visited the ER but the outcome once leaving pharmacy is unknown. Called patient to check in on 5/4 and was unable to reach. Left voicemail to return pharmacy call if desired. More
2839364 54 M 05/04/2025 PNC20
 PFIZER\WYETH
 LG5579
Extra dose administered Extra dose administered
Patient received Prevnar20 on 2/28/24 therefore this is a second (duplicate) dose. Patient received Prevnar20 on 2/28/24 therefore this is a second (duplicate) dose.
2839365 66 F PA 05/04/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 93N4J
Erythema, Rash, Skin warm, Swelling Erythema, Rash, Skin warm, Swelling
red, hot, swollen, rash red, hot, swollen, rash
2839366 66 F KY 05/04/2025 FLU3
 SANOFI PASTEUR
 u8519ca
Gait disturbance, Guillain-Barre syndrome, Pain in extremity, Paraesthesia Gait disturbance, Guillain-Barre syndrome, Pain in extremity, Paraesthesia
Received the vaccine and a few days later while laying in bed noticed tingling in her feet, the ting... Received the vaccine and a few days later while laying in bed noticed tingling in her feet, the tingling progressed to painful stabbing pain which made it hard to walk. This went on for months as it slowly got better. Her doctor suspects it was a milder case of Guillain-Barr๏ฟฝ Syndrome. More
2839367 47 F FL 05/04/2025 PNC20
 PFIZER\WYETH
 LG5577
Cellulitis, Injected limb mobility decreased, Pain in extremity Cellulitis, Injected limb mobility decreased, Pain in extremity
Patient reported pain and loss of motion that began day after immunization in left arm. Unsure when ... Patient reported pain and loss of motion that began day after immunization in left arm. Unsure when but patient reported she sought treatment at ED and was treated successfully for cellulitis. More
2839368 74 M NE 05/04/2025 COVID19
 MODERNA
 3044069
Injection site cellulitis, Injection site erythema, Injection site pain Injection site cellulitis, Injection site erythema, Injection site pain
Pt developed redness, pain and erythema at site, then cellulitis at the site and in the arm Pt developed redness, pain and erythema at site, then cellulitis at the site and in the arm
2839369 65 F CA 05/04/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 7L3ST
Contusion, Mass, Skin warm Contusion, Mass, Skin warm
Bruising with lump underneath, warmth that dissipated after 1 week Bruising with lump underneath, warmth that dissipated after 1 week
2839383 66 F CA 05/04/2025 COVID19
 MODERNA
 3044069
Injection site erythema, Injection site pain, Injection site swelling Injection site erythema, Injection site pain, Injection site swelling
REDNESS AND SWEELING AT INJECTION SITE. INJECTION SITE IS TENDER TO TOUCH. (RECOMEND BENADRYL AND WA... REDNESS AND SWEELING AT INJECTION SITE. INJECTION SITE IS TENDER TO TOUCH. (RECOMEND BENADRYL AND WAIT AND SEE) More
2839384 71 M WA 05/04/2025 COVID19
 MODERNA
 034C21A
Magnetic resonance imaging heart, Myocarditis, Pericarditis Magnetic resonance imaging heart, Myocarditis, Pericarditis
Pericarditis with slight myocarditis, treated with Prednisone. Pericarditis with slight myocarditis, treated with Prednisone.
โœ“
2839385 64 F AZ 05/04/2025 PNC20
TDAP
VARZOS
 PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 LX4484
D4J9L
47N3Y
Discomfort, Throat irritation, Throat tightness; Discomfort, Throat irritation, ... Discomfort, Throat irritation, Throat tightness; Discomfort, Throat irritation, Throat tightness; Discomfort, Throat irritation, Throat tightness More
Patient reported Discomfort , Scratchy throat and closing up 30 minutes after immunization. Epipen w... Patient reported Discomfort , Scratchy throat and closing up 30 minutes after immunization. Epipen was administered and Patient stabilized by emergency personnel. More
2839386 34 M PA 05/04/2025 ANTH
ANTH
 EMERGENT BIOSOLUTIONS
EMERGENT BIOSOLUTIONS
 300215a
300215a
Arthralgia, Discomfort, Hypoaesthesia, Mobility decreased, Pain; Pain in extremi... Arthralgia, Discomfort, Hypoaesthesia, Mobility decreased, Pain; Pain in extremity, Sleep disorder More
Significant shoulder pain including soreness and inability to move arm for several weeks after vacci... Significant shoulder pain including soreness and inability to move arm for several weeks after vaccine administration. After that the pain continued to persist though some limited range of motion has returned. Pain continues to be a dull ache almost 4 months post administration with some numbness and also inability to sleep on left side due to pain. Continued issue with range of motion, pain and discomfort even when not moving arm. Pain could be described as numb ache but sometimes increase to sharp pain radiating down arm More
โœ“
2839325 NM 05/03/2025 DTPPVHBHPB
RV5
 MSP VACCINE COMPANY
MERCK & CO. INC.
 U7947AA
2088619
No adverse event, Product storage error; No adverse event, Product storage error No adverse event, Product storage error; No adverse event, Product storage error
patient was administered ROTATEQ & VAXELIS during a temperature excursion.; No additional AE rep... patient was administered ROTATEQ & VAXELIS during a temperature excursion.; No additional AE reported.; This spontaneous report was received from an office manager concerning to a patient of unknown age and gender. The patient's medical history, historical drugs, known drug allergies, concurrent conditions, and concomitant therapies were not reported. On 24-Apr-2025, the patient was vaccinated with Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), Oral solution (lot #2088619, expiration date: 09-Mar-2026) 1 dosage form (1 dose), administered by Oral route and with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, Inactivated Poliovirus, ... (VAXELIS), Suspension for injection (lot #U7947AA, expiration date: 20-Oct-2026) 1 dosage form (1 dose; strength 0.5 mL) (route of administration not reported), both as Prophylaxis. However, the reporter stated that these doses underwent a temperature excursion at 0๏ฟฝC for 1 hour, no previous excursions had occurred, no additional events or details reported.; Reporter's Comments: More
2839326 IA 05/03/2025 MMRV
 MERCK & CO. INC.
 X023401
Expired product administered, No adverse event Expired product administered, No adverse event
No additional AE/PQC reported; Nurse called to report that an expired dose of PROQUAD was administer... No additional AE/PQC reported; Nurse called to report that an expired dose of PROQUAD was administered to 1 patient. Caller stated the product expired 3/20/2025 and was administered 4/30/2025. Caller stated product was never involved in a temperature excursion. Caller stated no pa; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-APR-2025, the patient was vaccinated with the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) lot #X023401, expiration date: 20-Mar-2025 (expired product administered) (strength, dose, route, and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (no details provided). It was reported that product was never involved in a temperature excursion. No adverse events reported. More
2839327 14 F NJ 05/03/2025 VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.

Y013346
Y013346








Y013346
Y013346
Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperatur... Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered; Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered; Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered; Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered; Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered; Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered; Autoimmune disorder, COVID-19, Extra dose administered, Pyrexia; Body temperature increased, Exposure to communicable disease, Extra dose administered More
Might have autoimmune disease; A HCP called to inquire how soon a patient (who is simultaneously bei... Might have autoimmune disease; A HCP called to inquire how soon a patient (who is simultaneously being worked up for an unknown autoimmune disease) could or would develop a fever after receiving an injection of VARIVAX. The HCP stated a patient was administered a dose of VARIVAX; the dose of VARIVAX should not have been administered on 04/30/2025, because the patient had already received two prior doses of VARIVAX on 09/18/2005 and 04/06/2009; COVID; This spontaneous report was received from a physician and refers to a 34-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-SEP-2005, the patient was vaccinated with first dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (dose, lot number and expiration date were not reported), 06-APR-2009, with the second dose (dose, lot number and expiration date were not reported) and on 30-APR-2025, with the third dose (valid lot number Y013346, expiration date: 02-AUG-2026) 0.5 mL, once, subcutaneously, all of them with sterile diluent (BAXTER STERILE DILUENT) (dose, lot number and expiration date were not reported) for vaccination due to an exposure to chickenpox approximately 7-8 days ago, but had two prior vaccinations in the past and the HCP who administered misread the chart and gave a third vaccine (prophylaxis). On an unknown date, the patient was worked up for an unknown autoimmune disease), on 30-APR-2025, she developed a fever (pyrexia) of 101.5 degrees Fahrenheit about 2 hours after the vaccine, on a unknown date in April 2025 (reporter as about one month ago) the patient had COVID, so she did not think the fever was related to COVID and the facility was going to also test the patient for the flu. The person who administered the vaccine read the patient's medical record incorrectly and the dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) should not have been administered on 30-APR-2025, because the patient had already received two prior doses of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) on 18-SEP-2005 and 06-APR-2009 (extra dose administered). The patient did not report any other adverse issues or side effects from the Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) administered on 30-APR-2025 and the healthcare provider (HCP) was not aware of the patient having experienced any adverse issues or side effects from the prior doses either. At the reporting time, the outcome of the events was not provided. The causal relationship between the events Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and sterile diluent (BAXTER STERILE DILUENT) was not provided. Upon internal review, the event autoimmune disease was determined to be medically significant. More
2839328 M CA 05/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 MG5S9
Product preparation issue Product preparation issue
Shingrix adjuvant only administered; Shingrix adjuvant only administered; This non-serious case was ... Shingrix adjuvant only administered; Shingrix adjuvant only administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number MG5S9, expiry date 30-MAR-2027) for prophylaxis. On 18-APR-2025, the patient received Shingrix. On 18-APR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix adjuvant only administered) and inappropriate dose of vaccine administered (Verbatim: Shingrix adjuvant only administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-APR-2025 The clinical manager called today to report that the adjuvant portion of the Shingrix vaccine was administered to a patient on April 18, 2025 which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. More
2839336 21 F FL 05/03/2025 HPV9
TDAP
 MERCK & CO. INC.
SANOFI PASTEUR
 y015179
u8232aa
Cold sweat, Lip discolouration, Pallor, Syncope, Unresponsive to stimuli; Cold s... Cold sweat, Lip discolouration, Pallor, Syncope, Unresponsive to stimuli; Cold sweat, Lip discolouration, Pallor, Syncope, Unresponsive to stimuli More
Within 5 minutes after vaccines, patient had syncope event with pale, clammy skin and gray lips. Sh... Within 5 minutes after vaccines, patient had syncope event with pale, clammy skin and gray lips. She was still breathing but unresponsive for about 3 minutes. It took about 45 minutes for recovery with monitoring by local EMS. More
2839337 62 F OH 05/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Erythema, Peripheral swelling, Skin warm Erythema, Peripheral swelling, Skin warm
Red, swollen and hot spreading down arm. Red, swollen and hot spreading down arm.
2839338 20 F FL 05/03/2025 UNK
 UNKNOWN MANUFACTURER
 EB499
Feeling abnormal, Hyperhidrosis, Loss of consciousness, Tremor Feeling abnormal, Hyperhidrosis, Loss of consciousness, Tremor
Patient 20 years old got a Boostrix vaccine (Tdap) on left arm (intramuscular) today 5/3/25 around 1... Patient 20 years old got a Boostrix vaccine (Tdap) on left arm (intramuscular) today 5/3/25 around 10:10 am and a few minutes after the vaccine she lost conscious and started having slight tremors that lasted a few seconds. After her tremors she said she felt like sweating and felt " weird" . She had to sit down for a few more minutes until a friend came to pick her up More
2839339 5 M CO 05/03/2025 FLU3
MNQ
 SEQIRUS, INC.
SANOFI PASTEUR

Oxygen saturation decreased, Unresponsive to stimuli, Vomiting; Oxygen saturatio... Oxygen saturation decreased, Unresponsive to stimuli, Vomiting; Oxygen saturation decreased, Unresponsive to stimuli, Vomiting More
Vomiting, unresponsive, low oxygen saturation Vomiting, unresponsive, low oxygen saturation
2839340 75 F GA 05/03/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 F4AC3
Injection site pain Injection site pain
Patient was previously vaccinated with Arexvy October 06, 2023. Patient is not experiencing any adv... Patient was previously vaccinated with Arexvy October 06, 2023. Patient is not experiencing any adverse events at this time, other than typical mild arm soreness at the injection site. More
2839341 80 M MD 05/03/2025 COVID19
 PFIZER\BIONTECH
 LN0591
Gait inability Gait inability
PER PT WIFE WAS UNABLE TO WALK FOR A COUPLE OF DAYS PER PT WIFE WAS UNABLE TO WALK FOR A COUPLE OF DAYS
2839342 62 F MD 05/03/2025 COVID19
 MODERNA
 8081260
Gait disturbance Gait disturbance
PER PATIENT WAS BARLEY ABLE TO WALK FOR A COUPLE OF DAYS PER PATIENT WAS BARLEY ABLE TO WALK FOR A COUPLE OF DAYS
2839343 56 F FL 05/03/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 xn575
Inappropriate schedule of product administration, Pain in extremity Inappropriate schedule of product administration, Pain in extremity
Spoke to patient about getting second dose of vaccine (Boostrix) since initial was given 2/5/25. Pat... Spoke to patient about getting second dose of vaccine (Boostrix) since initial was given 2/5/25. Patient only reported having sore arm. More
2839344 12 M 05/03/2025 MNQ
 SANOFI PASTEUR
Arthralgia, Axillary pain, Injection site discolouration, Peripheral swelling, T... Arthralgia, Axillary pain, Injection site discolouration, Peripheral swelling, Thrombotic thrombocytopenic purpura More
Arm swelling and pain under axilla and extending to elbow. TTP. Pink patches distal to injection si... Arm swelling and pain under axilla and extending to elbow. TTP. Pink patches distal to injection site. More
2839345 69 M FL 05/03/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 F4AC3
Injection site erythema, Injection site induration, Injection site mass, Injecti... Injection site erythema, Injection site induration, Injection site mass, Injection site swelling, Injection site warmth More
Raised hard red lump at site of injection (right arm), about the size of half a deck of cards, warm ... Raised hard red lump at site of injection (right arm), about the size of half a deck of cards, warm to the touch, within 24 hours of getting the vaccine. More
2839346 65 M OH 05/03/2025 PNC20
 PFIZER\WYETH
 LK6650
Injected limb mobility decreased, Injection site pain Injected limb mobility decreased, Injection site pain
patient had pain in left deltoid later the same day after injection that persisted for at least 4 we... patient had pain in left deltoid later the same day after injection that persisted for at least 4 weeks. pain 8/10 and was unable to lift his arm. first seen by PCP on 5/2/25 (about 4 weeks after injection). pain is improving but still 2/10. he declined imaging of area. no evidence of infection or DVT. suspect intramuscular hematoma vs localized reaction to vaccine. More
2839347 65 F WA 05/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 F35Y5
Erythema, Skin warm, Swelling Erythema, Skin warm, Swelling
Patient had normal reaction on day 1, mild redness/warmth/swelling. By day 2, swelling border had in... Patient had normal reaction on day 1, mild redness/warmth/swelling. By day 2, swelling border had increased , and by day 3 (Monday), border was between 2-3 inches. Patient went to the prescriber office and they decided to treat for possible cellulitis vs strong reaction to vaccine. Patient had possible reaction to doxycycline (mild rash) so was changed to cephalexin on 4/30/25. Had noticed slight improvement on doxycycline More
2839349 64 F WI 05/03/2025 HEP
VARZOS
 DYNAVAX TECHNOLOGIES CORPORATION
GLAXOSMITHKLINE BIOLOGICALS
 945664
EK225
Pain in extremity, Rash; Pain in extremity, Rash Pain in extremity, Rash; Pain in extremity, Rash
Patient said that she had a very sore arm on her left side (side shingrix was given) and developed a... Patient said that she had a very sore arm on her left side (side shingrix was given) and developed a rash on her upper body, her left arm and left arm pit. She noticed the rash on 4/21/25 and went to urgent care. At urgent care, she was prescribed prednisone. More
2839350 50 F TX 05/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 75X22
Influenza like illness, Injection site erythema, Injection site warmth Influenza like illness, Injection site erythema, Injection site warmth
Patient called reporting "flu like symptoms", redness at the injection site, and warmth at... Patient called reporting "flu like symptoms", redness at the injection site, and warmth at the injection site. Patient reports taking TYLENOL to help with these symptoms, and she does feel better now (5/2/25) More
2839351 61 M FL 05/03/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 4DS4N
Inappropriate schedule of product administration Inappropriate schedule of product administration
This error involves a 3rd dose of Twinrix that was administered 4 months early. First dose: 11/2/24 ... This error involves a 3rd dose of Twinrix that was administered 4 months early. First dose: 11/2/24 2nd dose: 12/7/24 3rd dose: 1/13/25 instead of May (This VAERS report) More
2839352 60 M NY 05/03/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 5yr3p
Rash, Rash pruritic Rash, Rash pruritic
Patient had a widespread rash develop over his legs that was very itchy within a week of getting the... Patient had a widespread rash develop over his legs that was very itchy within a week of getting the vaccine. He said that it mostly improved over the course of 2-3 weeks but has one itchy section by his ankle that his never improved until this day. More
2839353 89 M FL 05/03/2025 FLU3
 SANOFI PASTEUR
 TFAA2412
Acne, Furuncle, Pruritus Acne, Furuncle, Pruritus
PATIENT SAID HIS RIGHT ARM ITCHES AND NOW HE HAS A PIMPLE/BOIL WHITE WHITE PUS THE SIZE OF A BLACK ... PATIENT SAID HIS RIGHT ARM ITCHES AND NOW HE HAS A PIMPLE/BOIL WHITE WHITE PUS THE SIZE OF A BLACK PEPPER. RECOMMENDED HIM TO GO TO A DOCTOR AND GET ANTIBIOTIC JUST IN CASE. HE SAID HE DOES NOT WANT TO. TOLD HIM TO USE NEOSPORIN JUST IN CASE. HE SAID HE WILL GO TO THE DOCTOR IF IT GETS WORSE. REPEATED TO HIM THAT HE SHOULD GO AS SOON AS POSSIBLE IF HE'S CONCERN. REPORTING AS SOON AS HE INFORM US TODAY. More
2839354 61 M 05/03/2025 PNC21
RSV
TDAP
VARZOS
 MERCK & CO. INC.
PFIZER\WYETH
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 Y019157
LN5485
U8366AA
H97H2
Erythema, Pain, Pharyngeal swelling, Swelling face; Erythema, Pain, Pharyngeal s... Erythema, Pain, Pharyngeal swelling, Swelling face; Erythema, Pain, Pharyngeal swelling, Swelling face; Erythema, Pain, Pharyngeal swelling, Swelling face; Erythema, Pain, Pharyngeal swelling, Swelling face More
Patient received 4 vaccines and next day came to pharmacy complaining about throat swelling, redness... Patient received 4 vaccines and next day came to pharmacy complaining about throat swelling, redness on the administered arm and pain. His face was swollen and had redness on the right arm. Reecommended to urgent care to further treatment if needed. Patient did receive 3 more vaccines and those were give on left arm More
2839189 F IA 05/02/2025 HPV9
 MERCK & CO. INC.
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
No additional adverse event (AE)); HCP calling to inquire about a patient who received the first GAR... No additional adverse event (AE)); HCP calling to inquire about a patient who received the first GARDASIL 9 vaccine in 2017 and presents now for a second dose; This spontaneous report was received from a pharmacist and refers to a 24-year-old female patient. The patient's medical history, concurrent conditions, concomitant therapies, previous drug reactions and allergies were not reported. On an unknown date in 2017, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) injection, administered as prophylaxis (Lot No., expiration date, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided). It was stated that the patient presented now (on an unknown day in April 2025) for a second dose of the previous mention vaccine (inappropriate schedule of product administration). No additional adverse event was reported (No adverse event). More
2839190 F KY 05/02/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Pain in extremity Pain in extremity
arm soreness after administration; This non-serious case was reported by a nurse via call center rep... arm soreness after administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: arm soreness after administration). The outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Shingrix. It was unknown if the company considered the pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date : 28-APR-2025 The patient experienced arm soreness after administration of Shingrix. This case was linked with case US2025051115 reported by the same reporter, for different patient.; Sender's Comments: US-GSK-US2025051115:SAME REPORTER More
2839241 16 F PR 05/02/2025 MNP
 PFIZER\WYETH
Dizziness, Presyncope Dizziness, Presyncope
The patient had a vasovagal dizziness; This is a spontaneous report received from a Nurse from a sal... The patient had a vasovagal dizziness; This is a spontaneous report received from a Nurse from a sales representative. A 16-year-old female patient (not pregnant) received meningococcal group abcwy vaccine (PENBRAYA), on 10Mar2025 as dose number unknown, single (Batch/Lot number: unknown) at the age of 16 years for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: PRESYNCOPE (non-serious) with onset 10Mar2025, outcome "recovered" (10Mar2025), described as "The patient had a vasovagal dizziness". Therapeutic measures were taken as a result of presyncope. Additional Information: The patient did not receive any other vaccines on the same date as the suspect vaccine. The patient did not receive any other vaccines within 4 weeks PRIOR to the vaccine. Patient was not taking any other medications within 2 weeks of the event starting. The patient had a vasovagal dizziness treatment received for event vasovagal dizziness protocol, including lifting patient legs. Patient do not have known allergies. The information on the batch/lot number for meningococcal group abcwy vaccine will be requested and submitted if and when received. More
2839245 24 IA 05/02/2025 VARCEL
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
 X010523
Expired product administered, No adverse event; Expired product administered, No... Expired product administered, No adverse event; Expired product administered, No adverse event More
No adverse effects were reported/ no additional AE; VARIVAX was inadvertently administered to a pati... No adverse effects were reported/ no additional AE; VARIVAX was inadvertently administered to a patient on 4/30/2025, with an expiration date of 4/11/2025.; This spontaneous report was received from a Nurse and refers to a 24-year-old patient of unknown gender. The patient's medical history, concurrent conditions, previous drugs reactions or allergies and concomitant therapies were not reported. On 30-APR-2025, the patient was inadvertently vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), Injection (lot #X010523, expiration date: 11-APR-2025) at a dose of 0.5 mL (route of administration not provided) reconstituted with sterile diluent (BAXTER STERILE DILUENT) (dose description, lot # and expiration date were not reported) for prophylaxis (expired vaccine administered). No adverse effects were reported. More
2839246 71 F FL 05/02/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
Chills, Eye discharge, Eyelid function disorder, Nasal ulcer, Ophthalmic herpes ... Chills, Eye discharge, Eyelid function disorder, Nasal ulcer, Ophthalmic herpes zoster; Photophobia, Pyrexia, Seizure, Somnolence, Stomatitis More
high fever; shingles infection in left eye which has not resolved in over 7 months; convulsing; had... high fever; shingles infection in left eye which has not resolved in over 7 months; convulsing; had chills; sores in mouth; sore in nose; sleeping for an entire day; This serious case was reported by a consumer via call center representative and described the occurrence of ophthalmic herpes zoster in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 13-AUG-2024, the patient received the 2nd dose of Shingrix. In AUG-2024, less than a day after receiving Shingrix, the patient experienced ophthalmic herpes zoster (Verbatim: shingles infection in left eye which has not resolved in over 7 months) (serious criteria GSK medically significant), convulsion (Verbatim: convulsing) (serious criteria GSK medically significant and clinically significant/intervention required), fever (Verbatim: high fever), sleepiness (Verbatim: sleeping for an entire day), chills (Verbatim: had chills), mucosal sores (Verbatim: sores in mouth) and nasal ulcer (Verbatim: sore in nose). In AUG-2024, the outcome of the fever was resolved and the outcome of the sleepiness was resolved (duration 1 day). The outcome of the ophthalmic herpes zoster was not resolved and the outcome of the convulsion, chills, mucosal sores and nasal ulcer were resolved. It was unknown if the reporter considered the ophthalmic herpes zoster, convulsion, fever, sleepiness, chills, mucosal sores and nasal ulcer to be related to Shingrix. The company considered the ophthalmic herpes zoster and convulsion to be unrelated to Shingrix. It was unknown if the company considered the fever, sleepiness, chills, mucosal sores and nasal ulcer to be related to Shingrix. Additional Information: GSK Receipt Date: 24-APR-2025 The patient indicated that she got Shingrix shot 2 at a pharmacy. She said that less than 12 hours after the shot she began experiencing adverse reactions such as she had a high fever 102.6 for two days. She remembers sleeping for an entire day. She had chills and was convulsing such that her husband wanted to take her to hospital. But with extra blankets and changing the house temperature she was able to manage. She got sores inside her mouth and also inside her nose which she said were gross, horrible. She indicated that her left eye was running and that she could not even open her eye, so she went to urgent care. She had a shingles infection in her left eye that has persisted for over 7 months, and this was causing sensitivity to light. She did not had the lot number but she provided the name of the pharmacy and the pharmacy's phone number as the pharmacy should had the lot number on file. She went to the eye doctor twice a week and was prescribed numerous unspecified medications, but none have worked to clear the infection; Sender's Comments: Ophthalmic herpes zoster and Seizure are unlisted events which are considered unrelated to GSK vaccine Shingrix. More
2839247 F 05/02/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Abdominal pain, Dizziness, Headache, Hepatic enzyme increased, Vomiting Abdominal pain, Dizziness, Headache, Hepatic enzyme increased, Vomiting
Severely elevated liver enzymes; dizziness; Abdominal pain; headache; vomiting; This serious case wa... Severely elevated liver enzymes; dizziness; Abdominal pain; headache; vomiting; This serious case was reported by a consumer and described the occurrence of elevated liver enzymes in a 53-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 16-APR-2025, the patient received the 1st dose of Shingles vaccine. On 16-APR-2025, less than a day after receiving Shingles vaccine, the patient experienced elevated liver enzymes (Verbatim: Severely elevated liver enzymes) (serious criteria hospitalization), dizziness (Verbatim: dizziness) (serious criteria hospitalization), abdominal pain (Verbatim: Abdominal pain) (serious criteria hospitalization), headache (Verbatim: headache) (serious criteria hospitalization) and vomiting (Verbatim: vomiting) (serious criteria hospitalization). The outcome of the elevated liver enzymes, dizziness, abdominal pain, headache and vomiting were resolving. It was unknown if the reporter considered the elevated liver enzymes, dizziness, abdominal pain, headache and vomiting to be related to Shingles vaccine. It was unknown if the company considered the elevated liver enzymes, dizziness, abdominal pain, headache and vomiting to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 26-APR-2025 The patient took shingles vaccine and was hospitalized with abdomen pain, dizziness, vomiting, nausea, and severely elevated liver enzymes. She also mentioned, she had to have her blood drawn numerous times to make sure but becoming more stable. Reporter mentioned she was taken off all medications in the hospital due to potential increase in liver enzyme.; Sender's Comments: Hepatic enzyme increased and Dizziness are unlisted events which are considered unrelated to GSK Shingles vaccine. Abdominal pain, Headache and Vomiting are listed events which, due to the following criteria (insufficient information on medical history, concurrent conditions, concomitant medications and investigation details) are considered unrelated to GSK Shingles vaccine. More
โœ“
2839248 F WI 05/02/2025 VARZOS
VARZOS
VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
UNK
UNK
Eye swelling, Feeling abnormal, Headache, Herpes zoster, Incomplete course of va... Eye swelling, Feeling abnormal, Headache, Herpes zoster, Incomplete course of vaccination; Loss of consciousness, Malaise, Pain, Pruritus, Rash; Eye swelling, Feeling abnormal, Headache, Herpes zoster, Incomplete course of vaccination; Loss of consciousness, Malaise, Pain, Pruritus, Rash More
passed out; Shingles; She had declined to take the second dose of Shingrix; This serious case was re... passed out; Shingles; She had declined to take the second dose of Shingrix; This serious case was reported by a consumer via call center representative and described the occurrence of passed out in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included anxiety, macular degeneration, gastroesophageal reflux disease, allergy and cholesterol. Concomitant products included paroxetine, pantoprazole, montelukast, atorvastatin, ascorbic acid;betacarotene;cupric oxide;tocopheryl acetate;zinc oxide (Preservision), colecalciferol (Vitamin D 3), vitamins nos (Multivitamin) and paraffin (Mineral). On an unknown date, the patient received the 1st dose of Shingrix (intramuscular, left deltoid) and the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced passed out (Verbatim: passed out) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and incomplete course of vaccination (Verbatim: She had declined to take the second dose of Shingrix). The outcome of the passed out and shingles were unknown and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the passed out and shingles to be related to Shingrix. The company considered the passed out to be unrelated to Shingrix and Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date : 21-APR-2025 She reported that she received one dose of SHINGRIX about 5 or 6 years ago. Two weeks later she noted a severe headache. The following morning she had a swollen right eye. The rash on her face and side of head, into her hair line followed soon after. She stated that she was sick for 2 months. She stated the pain during this time was the worst she had ever experienced. The itching and weird feeling lasted a few months more. She reported that she had a visit with her Ophthalmologist during this time and passed out in the chair due to the close quarters and too many people in the room. She had declined to take the second dose of Shingrix. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.; Sender's Comments: Loss of consciousness is an unlisted event which is considered unrelated to GSK vaccine Shingrix (Dose 1 and Dose 2). More
2839249 M 05/02/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Aneurysm, Autoimmune disorder, Death Aneurysm, Autoimmune disorder, Death
Autoimmune disorder; he had an aneurysm and died; This serious case was reported by a consumer via s... Autoimmune disorder; he had an aneurysm and died; This serious case was reported by a consumer via sales rep and described the occurrence of autoimmune disorder in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced autoimmune disorder (Verbatim: Autoimmune disorder) (serious criteria death, GSK medically significant and other: Serious as per reporter) and aneurysm (Verbatim: he had an aneurysm and died) (serious criteria death). The patient died in APR-2025. The reported cause of death was autoimmune disorder and aneurysm. It was unknown if the reporter considered the autoimmune disorder and aneurysm to be related to Shingrix. The company considered the autoimmune disorder and aneurysm to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 29-APR-2025 The reporter was a neighbor of the patient who died. Reporter reported that after taken Shingrix, patient developed an autoimmune disorder in which he was prescribed continued use of steroids. An unknown amount of time later he had an aneurysm and died. The reporter stated death was sometime in last week (from the date of reporting) he/she thought and believed due to an aneurysm.; Sender's Comments: Autoimmune disorder and Aneurysm are unlisted events which are considered unrelated to GSK vaccine Shingrix.; Reported Cause(s) of Death: Autoimmune disorder; Aneurysm More
โœ“
2839250 05/02/2025 VARZOS
VARZOS
 UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
 UNK
UNK
Aphasia, Cardiac arrest, Guillain-Barre syndrome, Intensive care, Loss of contro... Aphasia, Cardiac arrest, Guillain-Barre syndrome, Intensive care, Loss of control of legs; Paralysis More
cardiac arrest; GBS/could not talk/lost control of legs; This serious case was reported by a consume... cardiac arrest; GBS/could not talk/lost control of legs; This serious case was reported by a consumer via interactive digital media and described the occurrence of cardiac arrest in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. In JUN-2022, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced cardiac arrest (Verbatim: cardiac arrest) (serious criteria hospitalization, GSK medically significant and life threatening) and guillain barre syndrome (Verbatim: GBS/could not talk/lost control of legs) (serious criteria hospitalization and GSK medically significant). The outcome of the cardiac arrest and guillain barre syndrome were not reported. The reporter considered the cardiac arrest and guillain barre syndrome to be related to Shingles vaccine. The company considered the cardiac arrest and guillain barre syndrome to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 19-APR-2025 This case was reported by a patient via interactive digital media. Patient took the first shot in June of 2022 and 10 days later lost control of legs and went to emergency room. Patient came down with the worst side effects of shot Guillain Barre syndrome and spent 6 weeks in the hospital, one week in ICU. Patient went into cardiac arrest and almost died and was completely paralyzed and could not talk. Patient stated that it was from the shot and was done with all shots.; Sender's Comments: Cardiac arrest and Guillain-Barre syndrome are unlisted events which are considered unrelated to GSK vaccine Shingles vaccine. More
โœ“ โœ“
2839251 05/02/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Inflammation, Surgery Inflammation, Surgery
inflammatory tailspin; This serious case was reported by a consumer via interactive digital media an... inflammatory tailspin; This serious case was reported by a consumer via interactive digital media and described the occurrence of inflammation in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (had Shingles 4 years before vaccine). On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced inflammation (Verbatim: inflammatory tailspin) (serious criteria clinically significant/intervention required). The outcome of the inflammation was not reported. It was unknown if the reporter considered the inflammation to be related to Shingles vaccine. The company considered the inflammation to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 26-APR-2025 This case was reported by a patient via interactive digital media. The patient reported that he/she had shingles then got the Shingles vaccine 4 years later. The patient stated he/she even spaced the two doses out a little further in hopes of not having any side effects. The vaccine was horrible. The patient stated, sent his/her body into an inflammatory tailspin resulting in surgery to correct. The patient stated that shingles was worse than childbirth, but the reaction to the vaccine was much easier.; Sender's Comments: Inflammation is an unlisted event which is considered unrelated to GSK Shingles vaccine. More
๐Ÿ“‹ Privacy Policy & Data Disclaimer